Azar Leads HHS as New Secretary
Former drug industry executive, Alex Azar, was confirmed by congress by bipartisan vote to be the new secretary of the U.S. Department of Health & Human Services (HHS). The former president of the Big Pharma company Eli Lilly & Co., “will now be in charge of buying more medications than anyone in the world,” according to NPR News. The good news is Azar says drug prices are too high and told members of the Senate Finance Committee they would be a priority.
As for Azar’s views on the Affordable Care Act, according to Healthcare Dive, “Azar has frequently criticized the ACA and would be unlikely to oppose more attempts to repeal or roll it back. He did however tell senators he would implement the law so long as it remains on the books.”
Azar replaces Tom Price, who resigned from HHS in September 2017, and Eric D. Hargan, who was sworn into office as deputy secretary on Oct. 6, 2017 and appointed as acting secretary.
Alex Azar, Photo credit Wikimedia by Wwsgconnect – Own work, CC BY-SA 4.0
Latest posts by Michelle Dick (see all)
- Medicare Now Considers Hospice Care a Post-acute Transfer - May 23, 2018
- Research and Codes Are Needed for Cannabis Treatment of Parkinson’s - May 22, 2018
- Dodge Healthcare Fraud in Your Practice - May 17, 2018